121 related articles for article (PubMed ID: 11691818)
1. Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations.
Franco N; Picard SF; Mege F; Arnould L; Lizard-Nacol S
Cancer Res; 2001 Nov; 61(21):7955-8. PubMed ID: 11691818
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of molecular alterations in fibroadenomas associated or not with breast cancer.
Franco N; Arnould L; Mege F; Picard SF; Arveux P; Lizard-Nacol S
Arch Surg; 2003 Mar; 138(3):291-5. PubMed ID: 12611577
[TBL] [Abstract][Full Text] [Related]
3. Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.
Lizard-Nacol S; Lidereau R; Collin F; Arnal M; Hahnel L; Roignot P; Cuisenier J; Guerrin J
Cancer Res; 1995 Oct; 55(19):4416-9. PubMed ID: 7671254
[TBL] [Abstract][Full Text] [Related]
4. Detection of sequential genetic alterations relevant for breast cancer development.
Niederacher D; Schnürch HG; An HX; Ellenberger I; Dall P; van Roeyen CR; Küppers V; Beckmann MW
Eur J Cancer Prev; 1996 Dec; 5(6):497-503. PubMed ID: 9061283
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of gene diagnosis in breast cancer].
Iwase H
Rinsho Byori; 1998 Sep; 46(9):869-75. PubMed ID: 9800471
[TBL] [Abstract][Full Text] [Related]
6. Metaphase and interphase cytogenetics in fibroadenomas of the breast.
Rizou H; Bardi G; Arnaourti M; Apostolikas N; Sfikas K; Charlaftis A; Polichronis A; Agnantis NJ; Pandis N
In Vivo; 2004; 18(6):703-11. PubMed ID: 15646810
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
8. Absence of association with cancer risk and low frequency of alterations at a p53 responsive PIG3 gene polymorphism in breast and lung carcinomas.
Gorgoulis VG; Liloglou T; Sigala F; Korkolis D; Yannoukakos D; Papalambros E; Asimacopoulos PJ; Papavassiliou AG; Kotsinas A
Mutat Res; 2004 Nov; 556(1-2):143-50. PubMed ID: 15491642
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
10. Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.
De Abreu FB; Pirolo LJ; Canevari Rde A; Rosa FE; Moraes Neto FA; Caldeira JR; Rainho CA; Rogatto SR
Anticancer Res; 2007; 27(2):1199-205. PubMed ID: 17465263
[TBL] [Abstract][Full Text] [Related]
11. Papillary lesions of the breast: a molecular progression?
Di Cristofano C; Mrad K; Zavaglia K; Bertacca G; Aretini P; Cipollini G; Bevilacqua G; Ben Romdhane K; Cavazzana A
Breast Cancer Res Treat; 2005 Mar; 90(1):71-6. PubMed ID: 15770529
[TBL] [Abstract][Full Text] [Related]
12. Lack of DNA copy number alterations revealed with comparative genomic hybridization in fibroadenomas of the breast.
Cavalli LR; Cornelio DA; Lima RS; Urban CA; Rone JD; Cavalli IJ; Haddad BR
Cancer Genet Cytogenet; 2004 Sep; 153(2):173-6. PubMed ID: 15350309
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast.
Barbosa ML; Ribeiro EM; Silva GF; Maciel ME; Lima RS; Cavalli LR; Cavalli IJ
Cancer Genet Cytogenet; 2004 Oct; 154(2):156-9. PubMed ID: 15474152
[TBL] [Abstract][Full Text] [Related]
14. Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression.
Tsuda H
Breast Cancer; 2009; 16(3):186-201. PubMed ID: 19472036
[TBL] [Abstract][Full Text] [Related]
15. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
[TBL] [Abstract][Full Text] [Related]
16. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
[TBL] [Abstract][Full Text] [Related]
18. Loss of hMSH2 expression in primary breast cancer with p53 alterations.
Spagnoletti I; Pizzi C; Galietta A; Di Maio M; Mastranzo P; Daniele S; Limite G; Pettinato G; Contegiacomo A
Oncol Rep; 2004 Apr; 11(4):845-51. PubMed ID: 15010883
[TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
